Page last updated: 2024-10-28

hexoprenaline and Coronary Disease

hexoprenaline has been researched along with Coronary Disease in 1 studies

Hexoprenaline: Stimulant of adrenergic beta 2 receptors. It is used as a bronchodilator, antiasthmatic agent, and tocolytic agent.

Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lechner, W1
Artner-Dworzak, E1
Heim, K1
Marth, C1
Puschendorf, B1

Other Studies

1 other study available for hexoprenaline and Coronary Disease

ArticleYear
Determination of light-chain myosin in pregnancy and under tocolysis.
    Journal of perinatal medicine, 1989, Volume: 17, Issue:6

    Topics: Coronary Disease; Female; Hexoprenaline; Humans; Immunoenzyme Techniques; Metoprolol; Myosins; Pregn

1989